Professional Portfolio ・ Call Guides
Call
Guides
Patient support call guides for pharma brands — written to help Care Navigators hold structured, empathetic conversations that keep patients informed, adherent, and supported at every stage of treatment.
Projects
2
Brands
SCEMBLIX® · PAH Companion withMe
Sector
Pharma / Patient Support
Role
Copywriter
01
SCEMBLIX®
Ongoing Treatment Support
This call guide supports Care Navigators in delivering empathetic, structured check-in calls for patients and caregivers taking SCEMBLIX®, helping ensure each conversation remains clear, supportive, and adherence-focused throughout long-term treatment.
Call Guide
Oncology
Adherence Support
Health Literacy
Multi-Call Series
Welcome & About SCEMBLIX
Program overview, indication, dosing schedule setup, side effect education
Indication
Side Effects
ISI Required
Getting Started
Dosing check-in, monitoring tests, insurance & Co-Pay Plus, self-advocacy
Adherence
Benefits / Insurance
Reactive: Rx Refills
Reinforcing Routines
Routine-building tips, missed dose guidance, monitoring check-in, refills
Routine Building
Missed Doses
Reactive: Dosing Review
Managing SCEMBLIX
Barriers to adherence, staying on track, HCP communication, support network
Adherence
Benefits / Insurance
Reactive: Rx Refills
Global Elements
Dosing check-in, monitoring tests, insurance & Co-Pay Plus, self-advocacy
Adherence
Benefits / Insurance
Reactive: Rx Refills
Call 1 — Side Effects Overview
Mandatory
Potential Side Effects · Serious
Low blood cell counts
SCEMBLIX® may cause low platelet counts (thrombocytopenia), low white blood cell counts (neutropenia), and low red blood cell counts (anemia). Blood tests are checked every 2 weeks for the first 3 months of treatment, then monthly or as needed.
“Tell your doctor right away if you have unexpected bleeding or easy bruising, blood in your urine or stools, fever, or any signs of an infection.”
SCEMBLIX® Ongoing Support — Call 1
Mandatory Content
Call 2 — Dosing Check-in
Mandatory
Patient’s Dosing Schedule
Staying on track with SCEMBLIX®
Ask if the patient has been able to stay on track with their dosing schedule, then branch based on response. Reinforce that SCEMBLIX® should be taken exactly as prescribed — either once daily or twice daily 12 hours apart — without food for 2 hours before and 1 hour after.
IF
YES — Acknowledge and reinforce. Remind patient not to break, crush, or chew tablets.
IF
NO — Offer to review dosing routine; use dosing wheel if patient has one.
SCEMBLIX® Ongoing Support — Call 2
Mandatory Content
Client
SCEMBLIX® / Novartis
Project Type
Ongoing Support Call Guide · 5 Calls
My Role
Copywriter — content development, tone refinement, health-literate patient-first messaging
The Work
What the copy needed to do
Support Care Navigators — not patients directly — with clear, branching scripts
Balance clinical accuracy with empathetic, accessible language
Reinforce adherence without minimizing the weight of long-term CML treatment
Equip navigators to handle insurance, refills, and safety questions in a single flow
02
PAH Companion withMe · Janssen
Warm Welcome
The Warm Welcome Call guide was created to help Care Coordinators deliver short, structured, and patient-friendly calls at the very start of the PAH treatment journey — clarifying roles, setting expectations, and outlining next steps so patients feel oriented rather than overwhelmed.
Call Guide
PAH
Cardiology
Health Literacy
Call Connection ~1 min
Intro, identity confirmation, voicemail scripts (3 attempts + courtesy), Care Partner identification
Mandatory
Voicemail Protocol
Call Greeting + Privacy ~3 miN
Monitoring consent, date-of-birth verification, Care Partner authorization, general disclaimer
Privacy approval
Care Partner Auth
3 Steps to Success ~5 min
Getting access, getting it shipped, starting medication — each step pauses for questions
Core Content
OPSUMIT / UPTRAVI
Encouragement for Questions ~1 min
Open Q&A before close; refers to FAQs and Responsive Talking Points for any questions raised
FAQ Handoff
Closing + ISI Recording ~1–2 min
Schedule next call, transition to OPSUMIT or UPTRAVI ISI audio recording, final close